Form 8-K - Current report:
SEC Accession No. 0001193125-25-263544
Filing Date
2025-11-04
Accepted
2025-11-04 07:12:25
Documents
26
Period of Report
2025-10-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d48107d8k.htm   iXBRL 8-K 59454
2 EX-2.1 d48107dex21.htm EX-2.1 477756
3 EX-10.1 d48107dex101.htm EX-10.1 57694
4 EX-10.2 d48107dex102.htm EX-10.2 59108
5 EX-10.3 d48107dex103.htm EX-10.3 30983
6 EX-10.4 d48107dex104.htm EX-10.4 122232
7 EX-10.5 d48107dex105.htm EX-10.5 122416
8 EX-10.6 d48107dex106.htm EX-10.6 123458
9 EX-10.7 d48107dex107.htm EX-10.7 67819
10 EX-10.8 d48107dex108.htm EX-10.8 68301
11 EX-10.9 d48107dex109.htm EX-10.9 45759
12 EX-99.1 d48107dex991.htm EX-99.1 28258
16 GRAPHIC g48107dsp1aaa.jpg GRAPHIC 6426
17 GRAPHIC g48107dsp1bbb.jpg GRAPHIC 3041
18 GRAPHIC g48107g1103141257634.jpg GRAPHIC 4006
  Complete submission text file 0001193125-25-263544.txt   1748396

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA evok-20251029.xsd EX-101.SCH 2860
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20251029_lab.xml EX-101.LAB 17992
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20251029_pre.xml EX-101.PRE 11267
29 EXTRACTED XBRL INSTANCE DOCUMENT d48107d8k_htm.xml XML 3671
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 251446431
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)